Results 231 to 240 of about 58,791 (313)
ABSTRACT Therapeutic options for newly diagnosed (ND) acute myeloid leukemia (AML) have increased in recent years, leading to a shift in the treatment paradigm from conventional, intensive chemotherapy toward targeted and less intensive therapy. Since 2017, there has been a surge in FDA approvals for novel therapies, including small molecule inhibitors
Thuy N. Ho +6 more
wiley +1 more source
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia. [PDF]
Groiss C +18 more
europepmc +1 more source
Case report: Autoimmune encephalomyelitis following cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [PDF]
Min Yang +4 more
openalex +1 more source
ABSTRACT This retrospective study evaluates the efficacy and safety of donor lymphocyte infusion (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT) in children. We describe the long‐term use of preemptive, prophylactic, and therapeutic DLI with a gradual dose increase in half‐log increments.
Dinah Walther +7 more
wiley +1 more source
Editorial: Immunology of allogeneic hematopoietic stem cell transplantation. [PDF]
Gurnari C +3 more
europepmc +1 more source
Non-myeloablative allogeneic hematopoietic stem cell transplants.
Fagioli, Franca +2 more
openaire +2 more sources
ABSTRACT Introduction Cryopreservation of peripheral‐blood‐derived hematopoietic stem and progenitor cells (PBSCs) has been used for decades, primarily for autologous transplantation. Now, in the era of new cellular therapies, the cryopreservation of allogeneic PBSCs may also become relevant.
Philipp Blüm +5 more
wiley +1 more source
Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomes. [PDF]
Sun HL +11 more
europepmc +1 more source

